Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 54 out of 100. Costs and economics

Topic: Risk, prevention and care in population studies

Results Of 162 034 eligible Medicare beneficiaries (mean [SD] age, 85.0 [7.9] years; 94 304 female [58.2%]), 51 191 (31.6%) were attributed to MSSP ACO. Sensitivity analyses using inverse probability weighting yielded similar results.

Key findings

Why it matters

This study looked at Medicare beneficiaries with dementia in accountable care organizations, including 51,191 attributed to the MSSP ACO out of 162,034 eligible beneficiaries. The available summary does not report findings on end-of-life care or health care spending outcomes.

Study details

Limitations

Quasi-experimental rather than randomised; ACO attribution can change year to year; claims capture billed advance care planning, not conversations that were not billed; fee-for-service only.

How this study scored 54/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 1 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 53 of the 98 points it could be judged on, which is 54 of 100. Total 54 of 100.53 of the 98 points we could judge = 54 of 100

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomised / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 53 of the 98 points we could judge it on, which is 54 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (JAMA Health Forum)
Journal's citation record 0 / 4 JAMA Health Forum: journal h-index 60 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 162,034 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Yusuke Tsugawa: h-index 47 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California, Los Angeles: institution h-index 1,923 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40343716)
Free to read — / 2 Access not recorded — left out of this score
Points 53 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 53 of the 98 points we could judge it on is 54 out of 100.
Total 54 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Zhang, J. J., Reuben, D. B., Walling, A. M., Zingmond, D. S., Damberg, C. L., Wenger, N. S., et al. (2025). End-of-Life Care and Health Care Spending for Medicare Beneficiaries With Dementia in Accountable Care Organizations. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2025.0731

Vancouver

Zhang JJ, Reuben DB, Walling AM, Zingmond DS, Damberg CL, Wenger NS, et al. End-of-Life Care and Health Care Spending for Medicare Beneficiaries With Dementia in Accountable Care Organizations. JAMA Health Forum. 2025. doi:10.1001/jamahealthforum.2025.0731. PMID: 40343716.

BibTeX

@article{zhang2025-40343716,
  author  = {Zhang, J. J. and Reuben, D. B. and Walling, A. M. and Zingmond, D. S. and Damberg, C. L. and Wenger, N. S. and Xu, H. and Ikesu, R. and Kaneshiro, G. S. and Klomhaus, A. and others},
  title   = {{End-of-Life Care and Health Care Spending for Medicare Beneficiaries With Dementia in Accountable Care Organizations}},
  journal = {JAMA Health Forum},
  year    = {2025},
  doi     = {10.1001/jamahealthforum.2025.0731},
  pmid    = {40343716},
  url     = {https://doi.org/10.1001/jamahealthforum.2025.0731}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Costs and economics

Also tagged “care”

996 studies in the library carry the topic tag “care”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 996 tagged studies.

Similar studies

More on Costs and economics

See all studies in Costs and economics →